You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Medtronic
McKinsey
AstraZeneca
Boehringer Ingelheim

Last Updated: February 25, 2020

DrugPatentWatch Database Preview

Litigation Details for Amgen Inc. v. F. Hoffmann-LaRoche LTD (D. Mass. 2005)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Biologic Drugs cited in Amgen Inc. v. F. Hoffmann-LaRoche LTD
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Amgen Inc. v. F. Hoffmann-LaRoche LTD (D. Mass. 2005)

Date Filed Document No. Description Snippet Link To Document
2007-09-07 1020 Claims Of U.S. Patent No. 5,441,868 And No. 5,618,698 That Invalidate Claims Of U.S. Patent No. 5,547,933…. 5,955,422 Regarding Obviousness-Type Double Patenting. (Toms, Keith) 7 September 2007 PACER External link to document
2007-09-10 1035 Claims of US Patent No. 5,441,868 and no. 5.618,698 That Invalidate Claims of US Patent NO. 5,547,933…. 5,955,422 Regarding Obviousness-Type Double Patenting. (Gottfried, Michael) 10 September 2007 External link to document
2007-10-15 1746 from marketing a drug that infringes U.S. Patent Nos. 5,441,868, 5,547,933, 5,618,698, 5,621,080, 5,756,349…by reference to two other patents. One reference patent, the ‘712 patent, issued from the original…immunize the ‘712 patent as a reference for double patenting, suggesting that the ‘496 patent did not maintain… rulings that the Amgen patents survive Roche’s obviousness-double patenting contentions, to resolve…150 claim 1 of the ‘422 patent and claims 3, 7, and 9 of the ‘933 patent, is not indefinite, even though External link to document
2007-06-11 478 Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 by F. Hoffmann-LaRoche External link to document
2007-06-11 479 Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 filed by F. Hoffmann-LaRoche External link to document
2007-06-11 480 Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 (Pursuant to Local External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
McKinsey
Dow
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.